Showing results (131-140 of 237) with videos related to
Sort By:
Pageof 24
Thrombosis and Haemostasis|June 3, 1987
Metformin decreases the high plasminogen activator inhibition capacity, plasma insulin and triglyceride levels in non-diabetic obese subjectsP Vague, I Juhan-Vague, M C Alessi, et al.Experimental Diabesity Research|June 17, 2004
C-peptide, Na+,K(+)-ATPase, and diabetesP Vague, T C Coste, M F Jannot, et al.Diabetes|September 1, 1987
In vivo insulin effect on ATPase activities in erythrocyte membrane from insulin-dependent diabeticsD Rahmani-Jourdheuil, Y Mourayre, P Vague, et al.Archives Des Maladies Du Coeur Et Des Vaisseaux|September 1, 1977
[Abnormalities of insulin secretion in coronary patients. Apropos of 67 cases]R Luccioni, P Vague, P Balansard, et al.The Journal of Clinical Investigation|May 1, 1993
Plasminogen activator inhibitor-1 synthesis in the human hepatoma cell line Hep G2. Metformin inhibits the stimulating effect of insulinF Anfosso, N Chomiki, M C Alessi, et al.Pathologie-Biologie|October 1, 1988
[The effect of pentoxifylline and propentofylline on the membrane fluidity of red blood cells in uncontrolled insulin-dependent (type 1) diabetic patients]C Roul, I Juhan-Vague, D Rahmani-Jourdheuil, et al.American Journal of Ophthalmology|August 1, 1995
Macular pattern dystrophy associated with a mutation of mitochondrial DNAP Massin, P J Guillausseau, B Vialettes, et al.Peptides|December 9, 2008
Significant lower VVH7-like immunoreactivity serum level in diabetic patients: evidence for independence from metabolic control and three key enzymes in hemorphin metabolism, cathepsin D, ACE and DPP-IVD Feron, A Begu-Le Corroller, J-M Piot, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 9, 2000
Specific deficiency of p56lck expression in T lymphocytes from type 1 diabetic patientsS Nervi, C Atlan-Gepner, B Kahn-Perles, et al.Diabetologia|May 1, 1997
Association of diabetic neuropathy with Na/K ATPase gene polymorphismP Vague, D Dufayet, T Coste, et al.Pageof 24